Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins

Journal of Lipid Research

Volumn 40, Issue 9, 1999, Pages 1695-1700

  Vélez Carrasco, Wanda ^a   Lichtenstein, Alice H ^a   Barrett, P Hugh R ^b   Sun, Zhiyong ^a   Dolnikowski, Gregory G ^a   Welty, Francine K ^a   Schaefer, Ernst J ^a  

^a TUFTS UNIVERSITY   (United States)

^b University of Washington   (United States)

Author keywords

ApoA I; ApoB 48; Compartmental analysis; Kinetics; Stable isotopes; TRL

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B48; HIGH DENSITY LIPOPROTEIN; LEUCINE; LIPOPROTEIN;

ADOLESCENT; ADULT; ARTICLE; CATABOLISM; FEMALE; GAS CHROMATOGRAPHY; HUMAN; ISOTOPE LABELING; KINETICS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIPOPROTEIN SECRETION; MALE; PRIORITY JOURNAL;

ADULT; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; FEMALE; HUMANS; KINETICS; LIPOPROTEINS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 0345425647     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Zannis, V. I., F. S. Cole, C. L. Jackson, D. M. Kurnit, and S. K. Karathanasis. 1984. Distribution of apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages. Biochemistry. 24: 4450-4455.
2. Ertel Miller, J. C., R. K. Barth, P. H. Shaw, R. W. Elliot, and N. D. Hatie. 1983. Identification of a cDNA clone for mouse apoprotein A-I (apoA-I) and its use in characterization of apoA-I mRNA expression in liver and intestine. Proc. Natl. Acad. Sci. USA. 80: 1511-1515.
3. Nicolosi, R. J., and V. I. Zannis. 1989. Apolipoprotein A-I of primates. J. Lipid Res. 25: 879-887.
4. Wu, A., and H. G. Windmueller. 1979. Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J. Biol. Chem. 254: 7316-7322.
5. Eggerman, T. L., J. M. Hoeg, M. S. Meng, A. Tombragel, D. Bojanovski, and H. B. Brewer, Jr. 1991. Differential tissue-specific expression of human apoA-I and apoA-II. J. Lipid Res. 32: 821-828.
6. Glickman, R. M., P. H. R. Green, R. S. Lees, and A. Tall. 1978. Apolipoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease. N. Engl. J. Med. 299: 1424-1427.
7. Green, P. H. R., R. M. Glickman, C. D. Saudek, C. B. Blum, and A. R. Tall. 1979. Human intestinal lipoproteins. Studies in chyluric subjects. J. Clin. Invest. 64: 233-242.
8. Anderson, D. W., E. J. Schaefer, T. J. Bronzert, F. T. Lindgren, T. Forte, T. E. Starzl, G. D. Niblack, L. A. Zech, and H. B. Brewer, Jr. 1981. Transport of apolipoproteins A-I and A-II by human thoracic duct lymph. J. Clin. Invest. 67: 857-866.
9. Ikewaki, K., D. J. Rader, J. R. Schaefer, T. Fairwell, L. A. Zech, and H. B. Brewer. 1993. Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radio-tracer methods. J. Lipid Res. 34: 2207-2215.
10. Schaefer, E. J., L. L. Jenkins, and H. B. Brewer, Jr. 1978. Human chylomicron apolipoprotein metabolism. Biochem. Biophys. Res. Commun. 80: 405-412.
11. Schaefer, E. J., M. G. Wetzel, G. Bengtsson, R. O. Scow, H. B. Brewer, Jr., and T. Olivecrona. 1982. Transfer of human lymph chylomicron constituents to other lipoprotein density fractions during in vitro lipolysis. J. Lipid Res. 23: 1259-1273.
12. Eisenberg, S. 1984. High density lipoprotein metabolism. J. Lipid Res. 25: 1017-1046.
13. Cohn, J. S., E. J. Johnson, J. S. Millar, S. D. Cohn, R. W. Milne, Y. L. Marcel, R. M. Russell, and E. J. Schaefer. 1993. Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRI.) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J. Lipid Res. 34: 2033-2040.
14. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28: 1379-1388.
15. Havel, R., H. Eder, and J. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
16. McNamara, J. R., and E. J. Schaefer. 1987. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin. Chim. Acta. 166: 1-8.
17. Contois, J., J. R. McNamara, C. Lammi-Keefe, P. W. Wilson, T. Massov, and E. J. Schaefer. 1996. Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin. Chem. 42: 507-514.
18. Ordovas, J. M., J. P. Peterson, P. Santaniello, J. S. Cohn, P. W. Wilson, and E. J. Schaefer. 1987. Enzyme-linked immunosorbent assay for human plasma apolipoprotein B. J. Lipid Res. 28: 1216-1224.
19. Cohn, J. S., D. A. Wagner, S. D. Cohn, J. S. Millar, and E. J. Schaefer. 1990. Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein ApoA-I production in human subjects using deuterated leucine. Effect of fasting and feeding. J. Clin. Invest. 85: 804-811.
20. Cobelli, C., G. Toffolo, D. M. Bier, and R. Nosadini. 1987. Models to interpret kinetic data in stable isotope tracer studies. Am. J. Physiol. 253: E551-564.
21. Reeds P. J., D. L. Hachey, B. W. Patterson, K. J. Motil, and P. D. Klein. 1992. VLDL apolipoprotein B-100, a potential indicator of the isotopic labeling of the hepatic protein synthetic precursor pool in humans: studies with multiple stable isotopically labeled amino acids. J. Nutr. 122: 457-466.
22. 3]leucine. J. Lipid Res. 33: 907-914.
23. Cohn, J. S., J. R. McNamara, S. D. Cohn, J. M. Ordovas, and E. J. Schaefer. 1988. Postprandial plasma lipoprotein changes in human subjects of different ages. J. Lipid Res. 29: 469-479.
24. Welty F. K., A. H. Lichtenstein, P. H. R. Barrett, G. G. Dolnikowski, J. M. Ordovas, and E. J. Schaefer. 1997. Production of apolipoprotein B-67 in apolipoprotein B-67/B-100 heterozygotes: technical problems associated with leucine contamination in stable isotope studies. J. Lipid Res. 38: 1535-1543.
25. Karpe, F., T. Olivecrona, A. Hamsten, and M. Hultin. 1997. Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants. J. Lipid Res. 38: 949-961.